HomeCompareOBDCF vs PFE

OBDCF vs PFE: Dividend Comparison 2026

OBDCF yields 886.92% · PFE yields 6.20%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 OBDCF wins by $1.09M in total portfolio value
10 years
OBDCF
OBDCF
● Live price
886.92%
Share price
$0.23
Annual div
$2.00
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1.14M
Annual income
$4,984.35
Full OBDCF calculator →
PFE
Pfizer Inc.
● Live price
6.20%
Share price
$27.76
Annual div
$1.72
5Y div CAGR
13.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$51.1K
Annual income
$27,210.54
Full PFE calculator →

Portfolio growth — OBDCF vs PFE

📍 OBDCF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodOBDCFPFE
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, OBDCF + PFE cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
OBDCF pays
PFE pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

OBDCF
Annual income on $10K today (after 15% tax)
$75,388.03/yr
After 10yr DRIP, annual income (after tax)
$4,236.70/yr
PFE
Annual income on $10K today (after 15% tax)
$526.66/yr
After 10yr DRIP, annual income (after tax)
$23,128.96/yr
At 15% tax rate, PFE beats the other by $18,892.26/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of OBDCF + PFE for your $10,000?

OBDCF: 50%PFE: 50%
100% PFE50/50100% OBDCF
Portfolio after 10yr
$594.1K
Annual income
$16,097.44/yr
Blended yield
2.71%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PFE right now

OBDCF
No analyst data
Altman Z
12.8
Piotroski
2/9
PFE
Analyst Ratings
16
Buy
22
Hold
1
Sell
Consensus: Hold
Price Target
$27.50
-0.9% upside vs current
Range: $24.00 — $35.00
Altman Z
2.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

OBDCF buys
0
PFE buys
0
No recent congressional trades found for OBDCF or PFE in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricOBDCFPFE
Forward yield886.92%6.20%
Annual dividend / share$2.00$1.72
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-50%13.2%
Portfolio after 10y$1.14M$51.1K
Annual income after 10y$4,984.35$27,210.54
Total dividends collected$738.2K$60.1K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: OBDCF vs PFE ($10,000, DRIP)

YearOBDCF PortfolioOBDCF Income/yrPFE PortfolioPFE Income/yrGap
1← crossover$55,046$44,345.90$9,161$701.38+$45.9KOBDCF
2$172,967$114,068.21$8,610$859.79+$164.4KOBDCF
3$352,565$167,490.42$8,366$1,081.25+$344.2KOBDCF
4$536,779$159,533.50$8,483$1,405.66+$528.3KOBDCF
5$687,852$113,499.38$9,084$1,907.24+$678.8KOBDCF
6$803,966$67,964.15$10,418$2,732.78+$793.5KOBDCF
7$897,364$37,120.06$13,007$4,193.56+$884.4KOBDCF
8$979,540$19,360.90$18,010$7,005.87+$961.5KOBDCF
9$1,057,984$9,875.65$28,216$12,979.89+$1.03MOBDCF
10$1,137,027$4,984.35$51,081$27,210.54+$1.09MOBDCF

OBDCF vs PFE: Complete Analysis 2026

OBDCFStock

Obducat AB (publ) develops and supplies lithography solutions for the use in the production and replication of micro and nano structures worldwide. It offers EITRE, a semi-automated nanoimprint lithography for research and development purposes; SINDRE, a fully automated nanoimprint lithography system for high-volume manufacturing; EITRE Large Substrates, a semi-automated nanoimprint lithography tool for large substrates; and SINDRE Litho Track, a fully integrated nanoimprint lithography system. The company also provides installation, upgradation, remote support, and other support services. Its products are used in various markets, such as optical and photonic devices; LEDs and displays; MEMS and sensor devices; and bio and medical devices. Obducat AB (publ) was founded in 1989 and is headquartered in Lund, Sweden.

Full OBDCF Calculator →

PFEHealthcare

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Full PFE Calculator →
📬

Get this OBDCF vs PFE comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

OBDCF vs SCHDOBDCF vs JEPIOBDCF vs OOBDCF vs KOOBDCF vs MAINOBDCF vs JNJOBDCF vs MRKOBDCF vs ABBV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.